An Active Role of the ΔN Isoform of p63 in Regulating Basal Keratin Genes K5 and K14 and Directing Epidermal Cell Fate by Romano, Rose-Anne et al.
An Active Role of the DN Isoform of p63 in Regulating
Basal Keratin Genes K5 and K14 and Directing Epidermal
Cell Fate
Rose-Anne Romano, Kori Ortt, Barbara Birkaya, Kirsten Smalley, Satrajit Sinha*
Department of Biochemistry, State University of New York at Buffalo, Center for Excellence in Bioinformatics and Life Sciences, Buffalo, New York, United States of America
Abstract
Background: One major defining characteristic of the basal keratinocytes of the stratified epithelium is the expression of the
keratin genes K5 and K14. The temporal and spatial expression of these two genes is usually tightly and coordinately
regulated at the transcriptional level. This ensures the obligate pairing of K5 and K14 proteins to generate an intermediate
filament (IF) network that is essential for the structure and function of the proliferative keratinocytes. Our previous studies
have shown that the basal-keratinocyte restricted transcription factor p63 is a direct regulator of K14 gene.
Methodology/Principal Findings: Here we provide evidence that p63, specifically the DN isoform also regulates the
expression of the K5 gene by binding to a conserved enhancer within the 59 upstream region. By using specific antibodies
against DNp63, we show a concordance in the expression between basal keratins and DNp63 proteins but not the TAp63
isoforms during early embryonic skin development. We demonstrate, that contrary to a previous report, transgenic mice
expressing DNp63 in lung epithelium exhibit squamous metaplasia with de novo induction of K5 and K14 as well as
transdifferentiation to the epidermal cell lineage. Interestingly, the in vivo epidermal inductive properties of DNp63 do not
require the C-terminal SAM domain. Finally, we show that DNp63 alone can restore the expression of the basal keratins and
reinitiate the failed epidermal differentiation program in the skin of p63 null animals.
Significance: DNp63 is a critical mediator of keratinocyte stratification program and directly regulates the basal keratin
genes.
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Introduction
Keratin proteins belong to two distinct classes, type I acidic and
type II basic and represent the bulk of IF genes expressed in
epithelial cells [1]. Type I and type II keratins are often co-
expressed in specific pairs in both a tissue-specific and differen-
tiation-specific fashion. For example, the pair formed by type I
K14 and the type II K5 is characteristic of the mitotically active
basal cells of the epithelium that line the stratified surface of the
skin, digestive tract, genito-urinary tract and mammary glands
among other tissues and organs. As the proliferating basal
epithelial cells stop dividing and initiate a specialized program of
differentiation, they down-regulate the expression of K5 and K14
and induce the expression of new sets of keratin genes depending
upon the particular tissue in which they are located [2]. The
restricted expression pattern of the basal-specific keratin genes is
established during embryonic development and is thought to be
controlled primarily at the transcriptional level. Indeed, during
early embryonic morphogenesis, a switch from expression of
simple epithelial keratins K8 and K18 to the stratified epithelial
markers K5 and K14 is a critical developmental event that marks
the stage of commitment and stratification of the epidermis [3,4].
Our understanding of the molecular mechanisms that govern
the transcriptional control of the basal keratin pair, K5 and K14,
has increased over the last few years. By using DNAse I
hypersensitive site mapping and reporter gene assays both in
keratinocytes in culture and in transgenic animals in vivo, we and
others have identified several cis-regulatory elements of the K5 and
K14 genes, which are important for their cell-type specific
expression [5,6,7,8,9,10]. Many of these regulatory elements are
scattered in the 59 flanking regions of the K5 and K14 gene and are
highly evolutionarily conserved. Biochemical studies of these DNA
sequences have uncovered the role of several transcription factors
such as AP-1, AP-2, Sp1 and Ets proteins in regulating K5 and
K14 gene expression. Interestingly, many of these transcription
factors are broadly expressed and not restricted to basal
keratinocytes. This observation had led to the suggestion that
combinatorial effects of ubiquitous transcription factors or
restricted co-activators might regulate the basal-keratinocyte
specific expression of K5 and K14. However, the identification
of transcription factor p63, which is highly restricted to basal
keratinocytes and directly regulates K14 gene expression by
interacting with an enhancer element has rekindled renewed
interest in this field [11].
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5623The transcription factor p63, a homolog of the tumor suppressor
p53, plays an important role in maintainingthe progenitor basal cell
populations in stratified epithelium such as those in the epidermis of
the skin [12]. Indeed, p63-null mice exhibit a striking block in skin
development [13,14,15]. In the absence of p63, the embryo is
encased in a primordial epithelial layer that fails to express the basal
markers K5 and K14 and does not undergo proper stratification
and differentiation. The skin phenotype observed in p63
2/2 mice
has led to the formulation of two hypotheses concerning the
biological role of p63 in epidermal development [16,17]. According
to one hypothesis, p63 may be important in maintaining the
proliferative potential of the stem cell population in the epithelium
[18]. Conversely, studies from a different independently generated
p63 null mouse model suggest that p63 may be required in the
commitment step to the stratified epithelial lineages [19]. Notwith-
standing these differences, it is clear that p63 is a critical
transcriptional regulator required for keratinocyte development
and differentiation [20]. One quirk that has compounded a
thorough and careful analysis of this transcription factor is the
myriad naturally occurring isoforms of p63.
The Trp63 gene encoding p63 gives rise to multiple functionally
distinct protein isoforms, including TAp63, which encodes for an
amino terminal transactivation domain (TA) and DNp63, which
lacks the N-terminal transactivation domain (DN), and is
synthesized from an internal promoter [21]. In addition, both
TA and DN transcripts are differentially spliced at the 39 end
generating proteins with unique C-termini, which are designated
as a, b, and c isoforms. Unlike the shorter b and c isoforms, the
p63a isoforms harbour a Sterile Alpha Motif (SAM) domain,
which is thought to mediate protein-protein interactions. One
controversy regarding p63 has been fueled by the conflicting
observations regarding the expression and function of the two
major N-terminal variant isoforms, primarily during epidermal
development. While it is unambiguous that DNp63 is highly
expressed in basal keratinocytes, the expression profile of TAp63
remains unclear. Earlier studies have suggested that TAp63 and
not DNp63 is the primary driver of the switch in expression of
simple epithelial keratins K8 and K18 to the stratified epithelial
markers K5 and K14 during early embryonic morphogenesis [19].
However, the fact that undisputed identification of TAp63 mRNA
and protein in mouse embryonic skin remains elusive and that the
TAp63 isoform-specific knockout mice have no discernible skin
phenotype warrants a re-evaluation of this observation [22]. Since
the DNp63 isoforms lack the amino-terminal sequences, it was
originally proposed that these proteins might act primarily as
dominant negative regulators [21]. However recent studies
indicate that DNp63 proteins have intrinsic biological activities
and can transcriptionally activate or repress target gene expression
[23,24,25,26,27,28]. Taken together, these findings have now
shifted the attention towards DNp63 and its perceived role in
actively dictating early epidermal development and governing
keratinocyte cell fate and lineage choices.
To address the expression profile of the two major isoforms of
p63, in the present study, we have utilized DN and TA specific
antibodies. Our studies confirm that in the early stages of skin
development, DNp63 proteins predominate and are hence likely to
mediate the commitment of ectodermal cells to an epidermal cell
fate. In support of this hypothesis we have identified a p63-
response element present in a highly conserved enhancer
corresponding to a DNAse I hypersensitive segment of the basal
keratinocyte restricted K5 gene. We provide biochemical evidence
that DNp63 can interact with and activate the K5 enhancer and
that all DNp63 isoforms are capable of inducing de novo expression
of K5 in a cell line that does not express detectable levels of p63 or
K5. Finally, we show that ectopic expression of various isoforms of
DNp63 in transgenic mouse lungs and in p63 null animals, leads to
de novo induction and restoration respectively, of both K5 and K14
gene expression. Taken together, our data provide additional
insights into the regulatory mechanisms governing K5 gene
expression, and suggest that K5, like its partner K14, is regulated
in a direct and similar fashion by DNp63.
Results
Development of p63 isoform specific antibodies
Prior to this study, the expression analysis of DN and TA p63
isoforms during various stages of epidermal development has been
performed using RT-PCR and in situ hybridization [19,29].
However, a systematic and careful analysis of the respective
proteins has not been undertaken with isoform-specific antibodies.
To address this shortcoming, we generated TA-specific antibodies
against the N-terminal portion of mouse TAp63 (amino acids 1–
115), a domain that is not shared with DNp63. We performed
Western blot analysis and immunofluorescence studies to address
specificity of the anti-TA antibodies. As shown in Figure 1A, the
anti-TAp63 antibodies detected the proteins at the expected sizes
only in HA epitope-tagged TAp63a, b,o rc transfected cells but
did not detect any band in the HA epitope-tagged DNp63 a, b,o r
c transfected cells, confirming the specificity of the newly
generated polyclonal antibodies. Western blot with anti-DNp63
(RR-14) antibodies demonstrated that the DNp63 proteins were
indeed expressed in the transfected cells and did not cross-react
with TA proteins as previously demonstrated. The expression of all
six isoforms of p63 proteins was verified by western blot with anti-
HA antibodies. Immunofluorescence studies further validated
these data, since anti-TA antibodies recognized TAp63 protein
localized predominantly in nuclei of transiently transfected HeLa
cells (Figure 1B). Finally, to examine the affinity of the anti-TAp63
polyclonal antibodies to TAp63 proteins in vivo, we performed
immunoflourescence on ovary sections where TAp63 has been
shown to be highly expressed. The staining pattern observed in the
ovarian follicles using our anti-TA antibodies matched exactly
with published reports, further confirming the specificity of our
newly developed antibodies (Figure 1C) [22].
Expression analysis of p63 proteins during embryonic
skin development reveals a predominance of the DNp63
isoforms
Having confirmed the specificity of the antibodies against the
two isoforms of p63, next we examined mouse embryonic sections
at different stages of development. At early embryonic day 10.5
and 11.5 (E10.5 and E11.5), the primitive epithelial lining encasing
the embryo expressed DNp63 as shown by a strong and uniform
nuclear staining with anti-DNp63 RR-14 antibodies (Figure 2).
Similar staining was observed with H-129 antibodies, which
recognize an epitope in the C-terminus of the longer p63a
isoforms. We also performed immunofluorescence with anti-K5
and anti-K14 antibodies and observed similar overlapping
expression profile to that of DNp63 except the staining was
cytoplasmic as expected. However, antibodies against TAp63
failed to show any staining suggesting that under similar
experimental conditions, the TAp63 proteins are either not
expressed or expressed at levels undetectable by our antibodies.
To follow the developmental pattern of the expression of p63
isoforms and the basal keratins, we performed additional
immunofluorescence studies at E14.5 and E16.5, two stages where
the epidermal stratification and differentiation programs are
distinctly matured as evident by histology (Figure 2, left panel).
DNp63 Directs Basal Cell Fate
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14 and H-129 antibodies detected strong DNp63 expression in the
basal cells of the stratified epidermis, whereas TAp63 was
undetectable. These results thus indicated that TAp63 proteins
are virtually non-existent in the developing skin epidermis,
whereas DNp63 and the K5/K14 keratin pair show strong and
overlapping expression in the basal keratinocytes at different stages
of embryonic development.
A hypersensitive site located upstream of the K5 gene is
evolutionarily conserved and is a direct transcriptional
target of p63
Recently we have shown that K14 expression is induced and
directly regulated by DNp63 [11]. Based on the fact that K5 is co-
expressed with K14 and likely to be coordinately regulated, we
hypothesized that K5 is also a direct transcriptional target of p63.
To test this hypothesis, we searched the genomic sequences in and
around the K5 gene for potential p63 binding sites. Previously,
using DNase I Hypersensitive (Hs) site mapping, we had identified
several Hs located within the 59 region of the K5 gene and shown
that these elements act as enhancers important for the transcrip-
tional control of K5 gene expression [6]. Hence we targeted our
search for p63-response elements (p63RE) in these potential
enhancer elements based on sequence similarities to the p63
consensus site as defined by a number of laboratories, including
our own [30,31,32,33]. Although several potential p63REs were
identified, one specific element embedded in Hs II region and
located , 2960 bp from the transcriptional start site showed the
highest level of sequence similarity. In addition, sequence
alignment of Hs II, demonstrated that this region was evolution-
arily conserved between human, mouse, cow, dog and oppossum,
suggesting the possibility of a functionally important role for this
DNA element (Figure S1). Next, we asked if the p63RE was
capable of interacting with DNp63.
The transcription factor DNp63 binds to p63RE DNA
sequences located within K5 Hs II region
In order to test if the K5 Hs II segment contains a bona fide p63
binding site, we performed Electrophoretic Mobility Shift Assays
(EMSA). Using a radiolabeled oligonucleotide probe correspond-
ing to this putative p63 binding site, we showed specific DNA-
protein complexes with nuclear extracts from HaCaT cells, an
immortalized human keratinocyte cell line which has been shown
to express high levels of DNp63 (Figure 3, lane 1). In order to
determine if DNp63 comprised this protein complex, we
performed competition assays. We utilized a number of different
probes including a previously identified p63 binding sequence
located within the K14 enhancer (KSC), a consensus p53 sequence
known to bind p63 (p53), a wild-type (WT), and a mutant (MT)
double-stranded oligonucleotide. While increasing amounts of the
KSC, p53, and WT oligonucleotides disrupted binding of the
complex, the MT oligonucleotide was unable to compete (Figure 2
lanes 2–9). These results suggested to us that the protein-DNA
complex likely consisted of p63.
To further confirm the identity of this nuclear complex,
supershift experiments were performed. The addition of an
antibody that specifically recognizes the DNp63 isoform of p63
(RR-14) results in a clear supershift (Figure 3, compare lanes 10 to
11). We also used a second commercially available antibody (H-
129), and observed a similar supershift of the complex (Figure 3,
Figure 1. Generation of TAp63-specific antibody. A) Specificity of the TAp63 antibody. Western blot analysis of whole cell extracts transfected
with various HA-epitope tagged isoforms of p63 show reactivity of the TAp63 antibody with cells transfected with HA-TAp63a, TAp63b, and TAp63c
only. B) Immunofluorescence of cells transfected with HA-TAp63c demonstrate the ability of the TAp63 antibody to detect TAp63 in cell culture in
vivo. DAPI nuclear staining is shown in blue, HA epitope tag is shown in red, TAp63 specific staining is shown in green and a merge is shown in the
lower panel. C) TAp63 expression in oocytes in sections of mouse ovary. TAp63 expression is shown in red and DAPI is shown in blue.
doi:10.1371/journal.pone.0005623.g001
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p63-DNA complex in agreement with the fact that these
keratinocytes do not express any detectable TAp63.These results
strongly suggest that the DNp63 and not the TA isoform of p63
binds to the specific p63RE present in Hs II of the K5 gene.
Occupancy of K5 Hs II by DNp63a in keratinocytes
In light of the results obtained from our in vitro experiments, we
next wanted to verify whether DNp63 was able to interact with Hs
II of the K5 gene in vivo, by performing ChIP assays in human
keratinocytes. Two separate antibodies against p63, one directed
specifically against DNp63 (RR-14) and one that recognizes the
p63a isoforms (H-129), as well as a control antibody (IgG) were
used for the ChIP experiments. To determine if DNp63 is
associated with this region, we used primers, which specifically
amplify Hs II region. As a negative control, primers that amplify a
genomic segment corresponding to gyceraldehyde-3-phosphate
dehydrogenase (GAPDH) were chosen. Our PCR data clearly
shows a specific amplification of the Hs II region in p63-
immunoprecipitated genomic DNA (Figure 3B). We further
quantified this result by real time PCR, which demonstrated a
6.6, and 5-fold enrichment of Hs II in samples immunoprecipi-
tated with RR-14 and H-129 respectively, versus control antibody
(Figure 3B). In contrast we did not observe any recruitment of
DNp63 to the control region corresponding to the GAPDH gene.
Due to the high level of sequence conservation observed for Hs II
between both human and mouse, we wondered whether DNp63
similarly occupied this region in the mouse K5 gene. We therefore
repeated our ChIP experiments utilizing primary mouse kerati-
nocytes. There was a specific localization of p63 to the mouse K5
59 genomic segment as evident by both regular PCR as well as real
time PCR results (Figure 3B). Taken together, our data
demonstrate that the DNp63a isoform of p63 binds to Hs II of
the K5 gene in both human and mouse keratinocytes in vivo,
supporting the possibility of a functional role for this p63 isoform
in the regulation of K5 gene expression.
Identification of an enhancer element corresponding to
Hs II within the K5 gene
Having demonstrated the occupancy of DNp63 to Hs II of the
K5 gene, we next investigated whether this segment could
function as an enhancer element. To determine the contribution
of Hs II element to keratinocyte-specific expression of K5, we
assayed for the ability of this element to activate transcription of a
luciferase (luc) reporter gene in transient transfection assays. We
therefore generated a construct in which the sequences
corresponding to Hs II were cloned upstream of the K5 minimal
promoter and luciferase reporter gene (HsIIK5Luc). In our
transfection assays using primary mouse keratinocytes, we found
that HsIIK5Luc is able to activate transcription 7-fold over the
K5 minimal promoter alone (K5Luc) (Figure S2A). A CMVLacZ
plasmid was co-transfected to serve as an internal control for
transfection efficiency. To test if the transcriptional activation of
Hs II was also observed with a heterologous promoter, we
generated an additional construct where Hs II was cloned
upstream of the minimal promoter of thymidine kinase (TK)
Figure 2. DNp63 is expressed during early mouse embryonic skin development. Isoform specific expression of p63 was analyzed during
various stages of skin development using three antibodies recognizing different p63 variants. Far left panel (panel 1) are H&E staining of skin using
paraffin embedded whole embryos. Panel 2 demonstrates expression of DNp63 (green) using the RR-14 antibody. Panel 3 shows expression of p63a
(green) using the H-129 antibody. K5 and K14 expression is also shown in green (panels 3 and 4 respectively). Far right panel reveals that TAp63
expression is absent during the developmental windows examined. Scale bar: 50 mm.
doi:10.1371/journal.pone.0005623.g002
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fold activation over the TK minimal promoter alone (TKLuc).
These data confirm the ability of HS II to act as an enhancer
element, likely contributing to the keratinocyte-specific expres-
sion of K5.
Finally to test the ability of various p63 isoforms to activate the
K5 enhancer element, we performed transient transfection
experiments in Ptk2 cells, which do not express endogenous
p63 or K5. The HsIIK5Luc construct was transfected into Ptk2
cells along with either a control expression plasmid pCMVHA,
or plasmids expressing various HA-epitope tagged isoforms of
p63. Again, a CMVLacZ plasmid was co-transfected to serve as
an internal control for transfection efficiency. As data presented
in Figure S2B indicate, expression of DNp63a, DNp63b, and
DNp63c isoforms led to 3–7 fold higher transcriptional activity
of the K5 enhancer element respectively, as compared to the
empty vector alone. Under similar conditions, activation by
TAp63a,T A p 6 3 b, and TAp63c isoforms was modest and
showed only 1.5–2 fold higher transcriptional activity of the K5
enhancer element, as compared to the empty vector alone.
These data suggest that various DNp63 isoforms can regulate the
expression of the K5 enhancer at the transcriptional level and
this activation is considerably more potent than the TAp63
isoforms.
Ectopic expression of multiple isoforms of p63 can
induce expression of K5
We have previously shown that ectopic expression of the various
isoforms of DNp63 are capable of inducing K14 expression and
that this induction is dependent upon the DNA-binding activity of
p63. In light of this finding, we wondered whether DNp63 was also
capable of transactivating K5 gene expression in cells grown in
culture. To test this hypothesis, we transfected Ptk2 cells with
expression plasmids encoding various HA-epitope tagged isoforms
of DNp63 and evaluated induction of the endogenous K5 gene.
Immunofluorescence studies reveal that cells expressing all three
DNp63a, DNp63b, and DNp63c isoforms, as seen by anti-HA
nuclear staining shown in red, also express the cytoplasmic
network of K5 staining, shown in green (Figure 4). Nuclei were
counterstained with 49,6-diamidino-2-phenylindole (DAPI) shown
in blue. Taken together, our studies demonstrate that ectopic
expression of all three isoforms of DNp63 is capable of inducing
expression of both K5 and K14 gene expression [11,34].
Expression of various isoforms of DNp63 in transgenic
mice induces K5 and K14 expression
To determine whether the DNp63 isoforms of p63 are capable
of inducing K5 and K14 gene expression in vivo, we ectopically
Figure 3. Binding of DNp63a to Hs II region of the K5 gene. A) EMSA reveals binding of DNp63a in nuclear extracts of HaCaT cells using a
radiolabeled probe corresponding to Hs II of the human K5 gene. Competition assays show that the KSC oligonucleotide, which contains a previously
identified DNp63a binding site within the K14 gene, competes with binding of Hs II probe (lanes 2–3). A p53 consensus (lanes 4–5) and a WT
oligonucleotide (lane 6–7) also compete for binding while a MT oligonucleotide did not affect Hs II binding (lanes 8–9). The highest complex (asterix)
is supershifted (arrow) with the addition of antibodies raised against various domains of DNp63 whereas anti-TA antibodies have no effect (lanes 10–
13). The lower complexes are likely to be non-specific. B) In vivo occupancy of DNp63a to the mouse and human K5 gene. ChIP was performed on
HaCaT or primary mouse keratinocytes using two separate antibodies recognizing DNp63a as well as a nonspecific IgG as indicated (left panel). Input
represents PCR amplification of 1% of the genomic DNA. Primers corresponding to a region of the GAPDH gene serves as a negative control. Right
panel shows results obtained from real-time PCR experiments.
doi:10.1371/journal.pone.0005623.g003
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control of a tetracycline-inducible promoter (HA-DNp63a or HA-
DNp63b) in simple lung epithelia. Transgene expression was
directed to lung epithelia using mice expressing the reverse
tetracycline-activator (rtTA) from the human Surfactant Protein-C
(SPC) promoter (SP-C/rtTA). HA-DNp63a or HA-DNp63b
transgenic mice, were bred to the SP-C/rtTA transgenic mice,
which have been previously shown to regulate doxycycline-
inducible expression of transgenes to single-layered lung epithelial
cells [35]. The SP-C promoter targets transgene expression to the
cuboidal surfactant-secreting type II alveolar cells, and to the distal
Clara cells of the lung epithelium. Neither of these cell types
expresses endogenous p63, K5, or K14. Doxycycline was
administered at embryonic day 0.5 (E0.5) of gestation to induce
transgene expression in the lung epithelia of the Bi-transgenic (BG)
mice (DNp63aBG or DNp63bBG). Lung biopsy specimens
obtained from E18.5 animals were stained with hematoxylin and
eosin. The staining data demonstrated that ectopic expression of
both the DNp63 isoforms resulted in severe alterations in lung
alveolar epithelial morphology, including squamous metaplasia in
BG animals as compared to WT control littermates (Figure 5).
Moreover, immunofluorescence staining revealed that sustained
expression of both DNp63a and DNp63b to the distal airway
epithelium of the lungs, induced de novo expression of both K5 and
K14. Staining of the lung tissue sections with HA antibody allowed
us to confirm the ectopic expression of the DNp63 proteins in the
lung epithelial cells. In addition, we also examined expression of
Thyroid Transcription Factor I (TTF1), a known marker of the
lung epithelial cells targeted by the SP-C promoter, which showed
overlapping expression with DNp63 (data not shown) [36]. As
shown in ure 5C, lung epithelial cells expressing the DNp63
transgene (green) also strongly expressed both K5 and K14 (red).
This is in stark contrast to lung sections from wild type control
littermate animals, which do not express the transgene and not
show any staining for the basal keratins (data not shown).
Interestingly, a subpopulation of K5 and K14+ve lung cells did
not show detectable levels of p63, this could be possibly due to
differences in protein stability or detection sensitivity or to
unknown cell non-autonomous effects of the ectopically expressed
DNp63. Taken together, these results indicate that ectopic
expression of both DNp63a and DNp63b are sufficient to commit
a single-layered epithelium to an epidermal cell fate. To examine
whether these altered lung cell types expressing DNp63 further
commit to a keratinocyte differentiation program, we stained BG
lung tissues with antibodies against K1 and K10, which are
characteristic markers of skin keratinocytes of the differentiated
spinous layer. Surprisingly, BG lung epithelium, unlike WT
control lungs exhibited strong expression of K1/K10 further
validating the notion that expression of DNp63 alone was sufficient
to trigger the transformation of lung cells along a stratifying
epidermal pathway (Figure S3).
Rescue of p63-null skin phenotype by DNp63 expressing
transgenics using a Tet inducible system
TP63-deficient animals that lack all isoforms of p63 display a
severe skin phenotype and die soon after birth. One previous study
Figure 4. Three major isoforms of DNp63 can induce expression of K5 in cell culture. Ptk2 cells were transfected with plasmids encoding
different HA-epitope tagged isoforms of DNp63 as indicated. Cells were stained with antibodies detecting HA (red) and K5 (green). Nuclei are stained
with DAPI (blue). 406magnification is shown.
doi:10.1371/journal.pone.0005623.g004
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TAp63a or both these isoforms together in a p63 null animal by
using the K5 promoter [37]. Interestingly, a partial rescue was
observed in p63 null animals, which expressed DNp63a but not
with TAp63a. Having established the Tet-inducible system, we re-
examined the effects of over expression of DNp63 in the p63 null
background. Our experimental plan is different from the published
study on several accounts. First, we overexpressed DNp63 in the
basal skin keratinocytes in an inducible fashion by utilizing the K5-
promoter-Tet driver animals and second, the p63 knockout allele
used in our study is different from the one previously used. This is
important since it has been reported that the two p63 knockout
alleles exhibit subtle but distinctly different skin phenotypes
[13,14]. Finally, we tested both DNp63a and DNp63b for their
potential efficiency and functional role in the in vivo rescue
experiments. Bi-transgenic animals that expressed either DNp63a
or DNp63b did not completely restore the epidermal integrity of
the p63 null animals as the animals perished soon after birth.
However, upon histological examination, several areas were found
to contain properly developed and stratified epidermis (Figures 6
and S4). Upon immunoflourescent staining, we observed strong
expression of the basal markers K5 and K14, a feature completely
absent from the p63 null newborn skin. Furthermore, staining
these areas with the antibodies against p63 confirmed that p63 was
indeed expressed in these focal areas and was confined to the basal
layer. In agreement with the histological features, additional
markers of differentiation such as K1, K10 (spinous layer) and
filaggrin (granular layer) were also prominently expressed in focal
areas of fully matured epidermis. Collectively, these data confirm
results obtained from prior studies and suggest that the DNp63a
and DNp63b isoforms alone are competent in initiating the
expression of basal markers and stratification.
Discussion
During embryonic development, the commitment of the
epithelial cells to a stratified epidermal lineage is thought to
initiate with the induction of the basal keratin pair K5 and K14
[38]. The association of the K5/K14 IF network with the
proliferating basal keratinocytes of the skin is a distinguishing
feature that persists throughout the life of an organism. One path
to a better understanding of the regulatory mechanisms that
Figure 5. DNp63 can induce de novo expression of K5 and K14 in single-layered lung epithelia. A) Schematic depicting the mating
scheme used to generate transgenic animals expressing the HA-DNp63 transgene in single-layered lung epithelium using the surfactant protein C
(SPC) promoter in a tetracycline inducible fashion. B) Gross morphology of E18.5 lung tissue sections stained with H&E from control animals and bi-
transgenic animals (DNp63aBG and DNp63bBG). Bi-transgenic animals exhibit squamous metaplasia. Scale bar: 50 mm. C) Lung tissue sections from
E18.5 stained with antibodies detecting HA epitope tag (green) and K5 or K14 (red) reveal expression of the transgene in bi-transgenic animals. Dapi
staining is shown in blue. Tissues from bi-transgenic animals demonstrate induction of K5 and K14 expression (red staining) as compared to control
littermates.
doi:10.1371/journal.pone.0005623.g005
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cell fate and subsequent stratification and differentiation involves
identification of transcription factors that control the regulation of
K5 and K14. Our prior studies identified a number of
evolutionarily conserved DNase I Hs elements scattered in the
59 region of the K5 and K14 gene. We had shown that various
transcription factors including those belonging to AP-1, AP-2 and
Ets family were important in mediating the activity of K5 and K14
enhancers [5,6,7]. However, recent studies have shown that in
addition to these factors, the transcription factor p63 directly
regulates K14 gene expression and plays a central role in the
development of the keratinocyte lineage [11,37].
Despite the growing evidence of the important role of p63 in
skin biology, one of the main unresolved issues revolves around the
expression profile, transcriptional activity and biological role of its
two major isoforms, DNp63 and TAp63. Initial studies, similar to
those described in this paper led to an interesting hypothesis,
mainly that TAp63 isoforms are required for commitment to a
stratified cell lineage during embryonic skin development [19,39].
This ‘‘commitment’’ model further suggests that the dominant
negative DNp63 function is required to oppose TAp63 isoforms to
achieve proper differentiation. According to this study, TAp63 was
expressed in the early ectodermal cells prior to the simple
epithelial to epidermal switch. Furthermore it was capable of
inducing the expression of K14 when ectopically expressed in
epithelial cells and causing a squamous metaplasia when expressed
in lung epithelium of transgenic mice. Indeed, the argument that
had supported the notion that TAp63 was the driver for
commitment was the fact that under similar experimental
conditions, DNp63 failed to induce basal keratins both in cell
culture and in transgenic mice.
Our data presented in this paper clearly argues against the
model in which TAp63 proteins are the only isoforms that are
competent in conferring a basal-cell like phenotype. We posit that
any question about the functional relevance of p63 isoforms should
begin with a clear understanding of where they are expressed.
While the expression of TAp63 and DNp63 has been evaluated at
the mRNA level by RT-PCR and by in situ hybridization
experiments, the results have been contradictory. While according
to one report, TAp63 mRNA can be detected in whole embryos as
early as E9.5, other studies suggest that while in embryonic skin
DNp63 mRNA is expressed at high levels, TAp63 mRNA could
barely be detected [19,29]. This discrepancy has been attributed to
experimental differences and due to the difficulties in processing
and manipulating mouse embryos at such early developmental
stages. With this controversy plaguing the p63 field, it is hence very
important that the relative expression of these two isoforms be
clearly evaluated, in particular at the protein level.
We have now thoroughly evaluated the expression of TAp63
and DNp63 in mouse embryonic skin using antibodies generated
in our laboratory that are specific to each isoform. These studies
unequivocally argue that the DNp63 and not TAp63 isoforms are
predominantly expressed at various stages of early embryonic skin
development and co-localize with the basal keratin markers K5
and K14. One of the arguments that have been made is that the
TA proteins are labile and hence notoriously difficult to detect
[40,41]. While this remains a possibility, our immunoflourescence
studies with anti-TA antibodies clearly show robust expression of
Figure 6. Ectopic Expression of DNp63b can partially rescue the p63 null phenotype. Top left panel shows H&E staining of p63
2/2 and
p63
2/2,DNp63b rescued animals. Scale bar: 50 mm. Remaining panels illustrate immunofluorescence staining using various antibodies as indicated
(in green). White hashed line demarcates the dermal epidermal boundary. Scale bar is 25 mm for immunofluorescence images.
doi:10.1371/journal.pone.0005623.g006
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obtained from the McKeon lab [22]. Interestingly, some recent
publications have reported expression of TAp63 in the suprabasal
layer of adult human skin [42,43]. Using our anti-TAp63
antibodies, so far we have failed to detect TAp63 in the
differentiated mouse keratinocytes — this could be due to
species-specific or age related differences. Taken together, these
results add to the growing body of evidence suggesting that under
normal physiological conditions, DNp63 is the primary isoform
expressed in keratinocytes.
Since p63 null animals lack epidermis and do not express K5
and K14, one potential role of p63 might be in regulating the
expression of these basal-specific genes. Indeed, our studies have
shown that p63 can directly interact with p63-responsive
regulatory elements present in the enhancer of the K14 gene
[11]. This data, coupled with the fact that p63 can activate or
induce expression of K14 in a wide variety of epithelial cells
strongly suggest that the basal keratin pair is a direct transcrip-
tional target of p63 [11,19,34,37,44]. Despite the fact that K5 and
K14 are typically co-expressed and hence likely to be coordinately
regulated by a similar set of transcription factors, so far no
experimental data have linked p63 to K5. To address this, we
examined previously described DNAse I hypersensitive sites that
are present in the 59 upstream region of the K5 gene. Here we
show that one of the most highly conserved enhancer segments
does indeed contain a p63RE. We provide biochemical data to
support the notion that DNp63 can bind to this element both by
EMSA and ChIP experiments and that all three isoforms of
DNp63 can induce K5 when ectopically expressed, thus
confirming that K5, similar to its partner K14, is a direct
transcriptional target of DNp63. Although we found no p63-
response elements in the proximal promoter region of K5, we
cannot rule out the recruitment of DNp63 to this region through
protein-protein interactions with other transcription factors such
as Sp1, as described for the DNp63 promoter for example [45].
Although our data clearly show that both the basal keratins K5
and K14 are direct p63 targets, there are some lingering questions.
For example, it is disconcerting to note that the global ChIP
studies on p63 targets have so far not identified the p63RE
described in this study. This could be potentially due to an
inherent limitation of the ChIP–Chip experiments in offering full
coverage of the genome or differences in choice of cell lines,
antibodies or other technical conditions. Hence, an argument can
be made that the p63 target database is still evolving and far from
completion, and there is a continuing need to find additional
bona-fide p63 targets [46]. Another observation that warrants
discussion is the result obtained from one knockdown study of p63,
which showed no change in K5 and K14 levels in regenerated
human tissue, in contrast to dramatic loss of these basal keratins in
p63-null mice [41]. As suggested by the Khavari group, it is
possible that regulation of the basal keratins differs in a
developmental context versus that of committed, postnatal cells.
Whereas the former process requires p63, the latter does not.
Finally it is worth mentioning that expression of p63 in cell culture
leads to a stronger and more consistent induction of K14 in
contrast to K5 (our unpublished data). This is not surprising
considering the growing evidence that the normal expression
patterns of K5 and K14 in various basal cells might not be
completely overlapping - a feature consistent with the notion that
there might be differential mode of transcriptional regulation of
K5 and K14 [47,48,49]. Interestingly, the induction of the basal
keratins is not observed in a small percentage of p63+ve cells. This
further suggests that the p63-mediated induction of specific genes
is probably a complex process that is dependent upon a host of
factors such as specific cell cycle stage, differentiation or epigenetic
status, or the availability and activity of other transcription factors
(such as AP-2) [50].
In an effort to probe the function of DNp63 in an in vivo setting,
we have generated an inducible transgenic system to express two
isoforms, DNp63a and DNp63b. We report that ectopic
expression of DNp63 in the lung epithelium results in a dramatic
switch in cell lineage commitment whereby the type II alveolvar
cells show clear evidence of metaplastic changes from a simple
epithelium to a stratified epithelium accompanied by robust
induction of both K5 and K14 as well as K1 and K10. It has been
shown that in the absence of p63, the stratified squamous
epithelium in cervix and vagina is transformed into a simple
columnar epithelium expressing uterine epithelial differentiation
markers [15]. Similarly, the ventral epithelium of the p63
2/2
bladder, where DNp63 is the predominant isoform is neither
committed to stratification nor differentiated [51]. These obser-
vations taken with our gain-of-function studies further reinforce
the idea that DNp63 is the primary instructive driver in
maintaining a stratified and differentiated epithelium. The
discrepancy between our findings and those from a prior study
where DNp63 failed to activate basal-specific gene expression is
likely due to differences in experimental set up or unknown
modifying factors that remains to be sorted out.
One recent report has examined the relative contribution of
DNp63 and TAp63 by reintroducing these isoforms separately or in
combination in p63 null mice with the help of K5 promoter-driven
transgenic animals that express DNp63 and TAp63 [37]. These
studies by Candi et al. suggest that only DNp63 and not TAp63
when expressed under the K5 promoter can partially rescue the skin
phenotype and that there is improved rescue when both DNp63 and
TAp63 are co-expressed. Thisadditive effectmight be due to unique
and complementary functions of DNp63 and TAp63 or simply the
results of an overall higher level of p63 due to the presence of both
isoforms.Ourinducibletransgenicmodelsystemallowedustorevisit
this issue. One major difference in the two studies is that we used a
different p63 null allele – an important consideration since it has
been reported that these two animals show subtle yet distinct
differences in the extent of epidermal integrity. While for the
experiments described by Candi et al, p63 null animals supposedly
containclumpsofdifferentiatedcellsintheepidermis,inthe p63 null
animals described in this study, no such clumps were observed in
new born animals, as has been reported [13,14,37]. However, in
agreement with prior studies, expression of DNp63 can partially
restore the p63 null skin phenotype and give rise to isolated, small
pockets of stratified epithelium. These epithelial structures morpho-
logically resemble a fully differentiated skin and express the entire
battery of differentiation markers from basal-specific K5 and K14,
earlydifferentiationK1andK10toterminaldifferentiationfilaggrin.
What is remarkable is the fact that even the shorter DNp63b
isoform, lacking a significant portion of the C-terminal domain is
capable of rescuing the skin phenotype. This observation suggests
that the SAM domain, a unique feature of p63 and p73 but not p53,
is dispensable for the epidermal cell fate and stratification inducing
properties of p63 – a finding that is further substantiated by the lung
squamous metaplasia phenotype of the SpC-DNp63b transgenic
animals. There are several potential reasons to account for only a
partial and patchy rescue of the p63 null skin by DNp63
overexpression - the K5/14 promoter is probably not active at an
early enough developmental stage, and more importantly, promoter
activity might be severely attenuated in the p63 null background
given the fact that p63 itself is a critical regulator of these basal-
specific promoters. It is important to highlight that exogenous
expression of DNp63 in ES-derived ectodermal cells efficiently
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knockdown of DNp63 leads to a block in epidermal proliferation
and development [34,52]. Thesedata coupled with the fact that TA-
specific knockout mice develop normal skin add further credence to
the idea that DNp63 might be the critical p63 isoform required for
epidermal morphogenesis [22]. Although the tide has clearly turned
in favor of DNp63, the final confirmation awaits the generation of
DNp63-specific knockout mice.
Materials and Methods
Ethics Statement
All mouse experiments were approved by the State University of
New York at Buffalo IACUC committee and carried out in
accordance with relevant national guidelines.
Generation of anti-TAp63 antibodies
A partial cDNA of mouse TAp63 (corresponding to the N-
terminal amino acids 1–115 unique to the TA isoforms) was
cloned into pGEX-5X-1 vector. Recombinant GST-TAp631-115
protein was purified from E.coli using the protocol as described
before [53]. Immunization of NZW rabbits was carried out with
recombinant GST-p63TA1-115 protein (Alpha Diagnostic). Se-
rum obtained from the third round of bleed of animal no.13
showed the highest antibody titer and was used for subsequent
purification and enrichment by antigen dependent affinity
chromatography. For this purpose, a His-tagged p63TA1-115
protein was generated by cloning the corresponding partial cDNA
of mouse TAp63 in pCOLD vector. The purification of His-
p63TA1-115 protein was performed according to standard
protocols described previously [30]. Purified His-p63TA1-115
was used to generate an affinity column by crosslinking it to
Cyanogen bromide-activated Sepharose 4B beads, and serum
containing the anti-p63TA antibodies was purified on it. After
extensive washing, antibodies were eluted with elution buffer
containing either KSCN or Glycine. Fractions with the highest
antibodies as judged by western blot analysis against TAp63 were
utilized for subsequent experiments.
Preparation of nuclear extracts, and Electrophoretic
Mobility Shift Assay (EMSA)
Nuclear extracts from HaCaT cells were prepared by standard
methods as described before [45]. EMSA’s were performed with
5 mg of nuclear extracts and end-labeled double-stranded oligonu-
cleotides as previously described [30]. Oligonucleotide sequences
used were as follows: K5HsII 59-GGCGGCCTTCAGCCTG-
TATCAACACAT-39, K5HsII Mut 59-GGCGGCCTTCAGCC-
TATATCAACACAT-39. Protein-DNA complexes were resolved
by gel electrophoresis on 5% non-denaturing polyacrylamide gel in
1X TBE buffer at room temperature. The gel was dried and
visualized by autoradiography after electrophoresis. Anti-p63
antibodies RR-14 and H-129 used for supershift experiments have
been described before [45].
Transient Transfections and Reporter Assays
MK (mouse keratinocytes) and Ptk2 cells were plated in six-well
plates the day prior to transfection. Transfections were performed
using Fugene 6 reagent (Roche) according to manufacturer’s
instructions.OnemicrogrameachofDNp63 and TAp63 expression
plasmids and luciferase reporter constructs weretransfectedper well
along with 0.25 mgo fCMVLacZ plasmid DNA to serve as an
internal control for transfection efficiency. Cells were harvested
48 hours post-transfection and reporter assays were performed as
described previously [45]. The K5 Hs II luciferase reporter
constructs were generated using pGL3 plasmid backbone contain-
ing the K5 or TK promoter that has been described before [6,7].
The Hs II region was amplified using primers, Forward 59
CTACAGGGTACCGTCCCG CTGCTTGGAACAGGGTGG
-39 and Reverse 59 CTACAGGCTAGCCCGGTTCCCCAG
CCCCCCAGGTGTG-39 and cloned using Kpn I and Nhe I
restriction enzymes.
Immunofluorescence
Ptk2 cells were plated at 75,000 cells/well in 12-well cell culture
plates lined with microscope cover glasses. Cells were transfected
at 30% confluency with 1 mg of expression plasmids containing
HA-epitope tagged mouse DNp63a, DNp63b, and DNp63c. Forty
eight hours post-transfection, cells were fixed on cover glasses with
4% paraformaldehyde for 10 minutes and washed in PBS for
30 minutes. Cells were permeabilized with 0.1% TritonX-100
(diluted in PBS) for 3 minutes, rinsed in PBS, and blocked for
2 hours with 5% BSA (in PBS). Samples were then incubated for
2 hours at room temperature with rat anti-HA (Roche) and rabbit
anti-Keratin 5 (gift from Julie Segre) at 1:500 dilution in 5% BSA.
Cells were then washed several times in PBS for 30 minutes.
Samples were further incubated for 45 minutes in secondary
antibodies, anti-rat IgG Alexa 568 (Molecular Probes Inc. Eugene,
OR) (1:750 dil.), anti-rabbit IgG FITC (BD Biosciences)
(1:500 dil.), and 49,6-diamidino-2-phenylindole (DAPI) (Molecular
Probes) at room temperature. Cells were washed several times in
PBS for 30 minutes and then briefly rinsed in tap water.
Microscope cover glasses were then mounted on microscope slides.
Lung tissues from E18.5 mouse embryos were embedded in
OCT and then frozen immediately on dry ice. Tissues were
sectioned to 5 mm and fixed in cold methanol for 5 minutes. Slides
were then washed in PBS three times for 5 minutes each. Tissues
where then circled with a PAP pen and blocked for 1 hour at room
temperature in 5% BSA, 0.1% TritonX-100 in PBS.
Whole new born animals were fixed overnight in 10% NBF,
dehydrated, paraffin embedded and sectioned to 4 mm thickness.
Slides were de-paraffinized and rehydrate through a graded
alcohol series. Antigen retrieval was performed by boiling slides in
a microwave for 20 minutes in antigen retrieval solution (10 mM
sodium citrate, 0.05% Tween-20, pH 6.0). Slides were allowed to
cool for 20 minutes and then rinsed briefly in PBS, circled with a
PAP pen and then blocked in 5% BSA, 0.1% TritonX-100 in PBS
for 1 hour.
The primary antibodies used at the indicated dilutions were
DNp63 (RR-14) (1:50; Romano et al. 2006), p63a (1:50; Santa
Cruz, H-129), K5, K14, K1, Filaggrin (1:200; gift from Dr Julie
Segre), K5 (1:200; Covance, CA), TAp63 (1:50), HA (1:200;
Roche), TTF1 (1:200; GeneTex, TX). Secondary antibodies used
were anti-rat IgG Alexa 568 (1:750; Molecular Probes), anti-
mouse IgG Alexa 488 (1:250; Molecular Probes), anti-rabbit IgG
Alexa 568 (1:750; Molecular Probes), and anti-mouse IgG FITC
(1:250; BD Biosciences). When staining with mouse monoclonal
antibodies, we used the reagents and protocol from the MOM
Basic kit (Vector Labs). Slides were mounted using Vectashield
Mounting Medium with DAPI (Vector Labs) viewed with a Nikon
FXA Fluorescence microscope. Images were captured using a
Nikon digital camera and analyzed using ImageJ, Adobe Photo-
shop, and Adobe Illustrator software. Lung images were captured
using Leica confocal microscopy and analyzed as above.
Generation of HA-DNp63a and HA-DNp63b Transgenic
animals
The HA-DNp63a and HA-DNp63b constructs were generated by
cloning each of the full length mouse DNp63a and full length mouse
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Tight plasmid (BD Bioscience). Transgenic mouse lines were
generated by separately microinjecting the purified DNA constructs
into fertilized mouse oocytes derived from a mixed genetic
background (C3Hf/HeRos X C57BL/10 Rospd). Seven HA-
DNp63a transgenic founder lines and nine HA-DNp63b transgenic
founder lines were identified by PCR analysis of tail DNA. The
following primers were used to genotype the HA-DNp63 founders:
forward (59- GGAGAATTCGAGCTCGGTACCCG – 39)a n d
reverse (59 – CGCTATTCTGTGCGTGGTCTG – 39). The
founders were then crossed to K5-tTA mice to determine which of
the founders express the transgene [54]. Detailed analysis of the Tet-
p63 transgenic animals will be described in a separate manuscript.
Animals
Protocols for mouse experimentation were performed according
to SUNY at Buffalo and RPCI IACUC protocols. The SPC-rtTA,
K5-tTA, and p63
+/2 mice have been previously described
[13,35,54]. Mice were mated with each other and noon of the
day the vaginal plug was observed was considered E0.5. The
pregnant SPC-rtTA dams were administered 2 mg/ml of
doxycycline supplemented with 5% sucrose in their drinking
water until embryos were collected at the indicated time. For
rescue experiments, K5-tTA/HA-DNp63a/p63
+/2 mice were
mated to K5-tTA/HA-DNp63a/p63
+/2 mice, in the absence of
doxycycline, to generate K5-tTA/HA-DNp63a/p63
2/2 animals.
Western Blots
Hela cells were plated at 150,000 cells/well in six-well cell
culture plates 24 hours prior to transfection. Cells were transfected
using Fugene 6 transfection reagent with 1 mg of each expression
plasmid encoding the various HA-epitope tagged p63 isoforms.
Cells were harvested 48 hours post-transfection, washed in PBS,
and centrifuged at 2,000 rpm for 5 minutes. Whole cell extracts
were prepared by resuspending the pellets in Laemmli Sample
Buffer (Bio-Rad). Approximately equivalent amounts of each
sample was denatured at 96uC for 10 minutes, separated by SDS-
PAGE, and transferred. Primary antibodies used at 1:2000
dilution include rat anti-HA (Roche), RR-14, and TAp63.
Secondary antibodies used at a 1:5000 dilution were immunoPure
goat anti-rat and goat anti-rabbit horseradish peroxidase-conju-
gated IgG (Pierce, Rockford, IL). Chemiluminescence detection of
horseradish peroxidase-conjugated secondary antibodies was
performed using the horseradish peroxidase stabilizer kit from
KPL (Gaithesburg, ND).
Cell culture
HaCaT cells were maintained in DMEM supplemented with
10% fetal bovine serum and 100 U/ml penicillin and 100 mg
streptomycin. Cells were routinely passaged at 90% confluency.
HeLa (human cervical adenocarcinoma) cells were grown in
DMEM supplemented with 10% fetal bovine serum, 100 U/ml
penicillin, and 100 mg/ml streptomycin. Ptk2 (rat kangaroo kidney
epithelial) cells were grown in Modified Eagle’s Medium with 10%
fetal bovine serum, 1% Modified Eagle’s Medium Non-Essential
Amino Acid solution, 100 U/ml penicillin, and 100 mg/ml
streptomycin. A spontaneously immortalized mouse keratinocyte
(MK) cell line was grown as described previously [45].
ChIP experiments
ChIP experiments with anti-p63 antibodies using cells in culture
have been described previously [23,25]. Primers used to amplify the
Hs II region of the human K5 gene were forward 59-CTGGCA-
GATGTGCATGCCAGCTGC-39 and reverse 59-CTCTTTGGC-
CTGGGCAGGACTCTG-39. Human glyceraldehydes-3-phos-
phate dehydrogenase control primers were forward 59-G A G -
TACGCTGCAGGGCCTCACTCCTTTTGC-39 and reverse 59-
CATGCCAGTGAGCTTCCCGTTCAGCTCAG-39.T h ef o l l o w -
ing primers were used to amplify the Hs II region of the mouse K5
gene, forward 59-GCAGAAGAGTCGTCTGGAAGC-39 and re-
verse 59-GCTGTGTTCCAGCAAGTT-39. Mouse glyceralde-
hydes-3-phosphate dehydrogenase control primers were forward 59-
GCTAGGACTGGATAAGCAGG-39 and reverse 59-G G T C -
CGGCTTGCACACTTC-39.
Supporting Information
Figure S1 Genomic sequence conservation of K5. Upper panel
shows a schematic of the various DNAse I Hs previously identified
in the human K5 gene [6]. The sequence of Hs II from various
species was obtained from the respective genome database and
aligned. Hs II reveals high sequence conservation among seven
species as indicated. The p63-response element is denoted by a
horizontal bar.
Found at: doi:10.1371/journal.pone.0005623.s001 (0.13 MB TIF)
Figure S2 Hs II of the K5 gene acts as an enhancer and is
activated by various p63 isoforms in reporter gene assays in mouse
keratinocytes. In the upper panel, a luciferase construct containing
Hs II upstream of the heterologous TK promoter (Hs IITK),
shows a three fold activation over the TK promoter alone (TK). In
contrast, a luciferase construct containing the Hs II upstream of
the human K5 promoter (Hs II K5), showed a 7.5 fold higher
activation as compared to the K5 promoter alone (K5). In the
lower panel, the Hs II K5 construct was co-transfected with
expression plasmids encoding various isoforms of p63 into Ptk2
cells. Luciferase values were determined and normalized against b-
galactosidase values. The corrected luciferase values for cells
transfected with empty vector pCMV-HA were set at 1.
Found at: doi:10.1371/journal.pone.0005623.s002 (0.04 MB TIF)
Figure S3 DNp63 can induce de novo expression of the
keratinocyte differentiation markers K1 and K10 in single-layered
lung epithelia. Lung tissue sections from E18.5 DNp63a BG
animal reveals de novo expression of K1 and K10 (green) as
compared to control animals. Transgene (HA) expression is shown
in red. Scale bar: 25 mm.
Found at: doi:10.1371/journal.pone.0005623.s003 (0.13 MB TIF)
Figure S4 Ectopic Expression of DNp63a can partially rescue
the p63 null phenotype. Top left panel shows H&E staining of
p632/2 and p632/2,DNp63a rescued animals. Inset is a higher
magnification demonstrating the partial rescue of the epidermis in
the transgenic animals. Remaining panels illustrate immunofluo-
rescence staining using various antibodies as indicated (in green) in
206magnification. The antibodies used were against DNp63 (RR-
14) and p63a (H-129). White arrowhead shows filaggrin
expression in the epidermis of the DNp63a/p632/2 animals.
White hashed line demarcates the dermal epidermal boundary.
Scale bar: 50 mm.
Found at: doi:10.1371/journal.pone.0005623.s004 (0.50 MB TIF)
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